drugset
drugset / Trial / NCT04447820

Study to Investigate the Efficacy and Pharmacokinetic Profile of K-877-ER Compared to K-877-IR

NCT04447820 ↗

Phase 2 Completed 96 enrolled Kowa Research Institute, Inc.
RandomizedParallel-groupOpen-labelTreatment

Summary

A study to evaluate the efficacy of K-877 extended release (ER) once daily (QD) compared to K-877 immediate release (IR) twice daily (BID).

Timeline

Start
2020-06-10
Primary completion
2020-12-03
Completion
2020-12-03

Drugs

EvaluationDrugModalityDoseRoute
Subject K-877 Unknown — Oral

Indications

hyperlipidemia